A SECOND “game-changing” Alzheimer’s drug shown to slow the progression of the disease has been approved in the UK. Donanemab, developed by pharmaceutical giant Eli Lilly, was ...
A new study finds that brain endurance training (BET) can improve attention and executive function (cognition), as well as physical endurance and resistance exercise performance.